haemoctin sdh 500
biotest pharma gmbh landsteinerstrasse 5, 63303 dreieich, germany - factor viii, human - powder and solvent for solution for injection - factor viii, human 50 iu/ml - antihemorrhagics
haemoctin sdh 1000
biotest pharma gmbh landsteinerstrasse 5, 63303 dreieich, germany - factor viii, human - powder and solvent for solution for injection - factor viii, human 100 iu/ml - antihemorrhagics
octanate, 50 iu/ml powder and solvent for solution for injection
octapharma (ip) limited - factor viii, human - powder and solvent for solution for injection - factor viii, human 50 iu/ml - antihemorrhagics
octanate, 100 iu/ml powder and solvent for solution for injection
octapharma (ip) limited - factor viii, human - powder and solvent for solution for injection - factor viii, human 100 iu/ml - antihemorrhagics
octanate lv 100 iu/ml powder and solvent for solution for injection
octapharma (ip) limited - factor viii, human - powder and solvent for solution for injection - factor viii, human 100 iu/ml - antihemorrhagics
octanate lv 200 iu/ml powder and solvent for solution for injection
octapharma (ip) limited - factor viii, human - powder and solvent for solution for injection - factor viii, human 200 iu/ml - antihemorrhagics
alphanine sd (coagulation factor ix- human kit
grifols usa, llc - coagulation factor ix human (unii: 6u90y1795t) (coagulation factor ix human - unii:6u90y1795t) - coagulation factor ix human 500 [iu] in 10 ml - alphanine sd is indicated for the prevention and control of bleeding in patients with factor ix deficiency due to hemophilia b. alphanine sd contains low, non-therapeutic levels of factors ii, vii, and x, and, therefore, is not indicated for the treatment of factor ii, vii or x deficiencies. this product is also not indicated for the reversal of coumarin anticoagulant-induced hemorrhage, nor in the treatment of hemophilia a patients with inhibitors to factor viii. none known.
csl chile human coagulation factor viii for injection 500iu
csl behring australia pty ltd - factor viii, quantity: 500 iu - injection, solution - excipient ingredients: water for injections - human coagulation factor viii is indicated for the treatment and prophylaxis of bleeding associated with factor viii deficiency due to haemophilia a.
csl chile human coagulation factor viii for injection 250iu
csl behring australia pty ltd - factor viii, quantity: 250 iu - injection, solution - excipient ingredients: water for injections - human coagulation factor viii is indicated for the treatment and prophylaxis of bleeding associated with factor viii deficiency due to haemophilia a.
csl ecuador human coagulation factor viii for injection 250iu
csl behring australia pty ltd - factor viii, quantity: 250 iu - injection, solution - excipient ingredients: water for injections - human coagulation factor viii is indicated for the treatment and prophylaxis of bleeding associated with factor viii deficiency due to haemophilia a.